News

Harmony (HRMY) Stock Tanks On Study Miss For Narcolepsy Drug

7 Mins read

Harmony Biosciences Overview

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is a Pennsylvania-based, commercial stage pharmaceutical company that joined the Nasdaq back in August 2020, its initial public offering raising ~$148m, via the issuance of ~6.1m shares priced at $24.

Read the full article here

Related posts
News

Azvalor Asset Management H2 2024 Letter

9 Mins read
Dear co-investor, 2024 was a year of sowing. Following the harvests of 2021 to 2023 (+122% in Azvalor International, +71% in Managers,…
News

Alt Season May Not Happen; Long-Term Bitcoin Bullishness

18 Mins read
Listen here or on the go via Apple Podcasts and Spotify With recent volatility in crypto, Mike Fay wonders how much has…
News

AMETEK: Long-Term Value Creator At Work (NYSE:AME)

1 Mins read
This article was written by Follow The Value Investor has a Master of Science with specialization in financial markets and a decade…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *